Neuroendocrine Tumors Are Enriched in Cowden Syndrome

Overview

Journal JCO Precis Oncol

Specialty Oncology

Date 2020 Sep 14

PMID 32923874

Citations 2

Authors

Alison Greidinger

Susan Miller-Samuel

Veda N Giri

Michele Sue-Ann Woo

Saranya Akumalla

Charnita Zeigler-Johnson

Scott W Keith

Daniel P Silver

Affiliations

Soon will be listed here.

Citing Articles

Extended spectrum of cancers in PTEN hamartoma tumor syndrome.

Yehia L, Plitt G, Tushar A, Liu D, Joo J, Ni Y NPJ Precis Oncol. 2025; 9(1):61.

PMID: 40050354 PMC: 11885834. DOI: 10.1038/s41698-025-00847-3.

Sinonasal Neuroendocrine Carcinoma in Adult Proteus Syndrome.

Sideris G, Nikolopoulos T, Sourla A, Korkolopoulou P, Papadakis P, Delides A Iran J Otorhinolaryngol. 2023; 35(131):321-324.

PMID: 38074478 PMC: 10701243. DOI: 10.22038/IJORL.2023.73128.3472.

Models in Pancreatic Neuroendocrine Neoplasms: Current Perspectives and Future Directions.

Forsythe S, Pu T, Andrews S, Madigan J, Sadowski S Cancers (Basel). 2023; 15(15).

PMID: 37568572 PMC: 10416968. DOI: 10.3390/cancers15153756.

References

Neychev V, Sadowski S, Zhu J, Allgaeuer M, Kilian K, Meltzer P . Neuroendocrine Tumor of the Pancreas as a Manifestation of Cowden Syndrome: A Case Report. J Clin Endocrinol Metab. 2015; 101(2):353-8. PMC: 5393589. DOI: 10.1210/jc.2015-3684. View

HAIBACH H, BURNS T, Carlson H, Burman K, Deftos L . Multiple hamartoma syndrome (Cowden's disease) associated with renal cell carcinoma and primary neuroendocrine carcinoma of the skin (Merkel cell carcinoma). Am J Clin Pathol. 1992; 97(5):705-12. DOI: 10.1093/ajcp/97.5.705. View

Kitazoe K, Hosijima Y, Aoki H, Kurinaga A, Ikeda Y, Shibata Y . [A case of Cowden's disease associated with rectal carcinoid]. Nihon Shokakibyo Gakkai Zasshi. 1998; 95(11):1244-8. View

Taylor A, Dodds W, STEWART E . Alimentary tract lesions in Cowden's disease. Br J Radiol. 1989; 62(742):890-2. DOI: 10.1259/0007-1285-62-742-890. View

Podsypanina K, Ellenson L, Nemes A, Gu J, Tamura M, Yamada K . Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc Natl Acad Sci U S A. 1999; 96(4):1563-8. PMC: 15517. DOI: 10.1073/pnas.96.4.1563. View

Koksal Y, Sahin M, Koksal H, Orhan D, Unal E, Alagoz E . Thyroid medullary carcinoma in a teenager with Cowden syndrome. Laryngoscope. 2007; 117(7):1180-2. DOI: 10.1097/MLG.0b013e318058a0b7. View

Pilarski R, Burt R, Kohlman W, Pho L, Shannon K, Swisher E . Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria. J Natl Cancer Inst. 2013; 105(21):1607-16. DOI: 10.1093/jnci/djt277. View

Papa A, Wan L, Bonora M, Salmena L, Song M, Hobbs R . Cancer-associated PTEN mutants act in a dominant-negative manner to suppress PTEN protein function. Cell. 2014; 157(3):595-610. PMC: 4098792. DOI: 10.1016/j.cell.2014.03.027. View

Scarpa A, Chang D, Nones K, Corbo V, Patch A, Bailey P . Whole-genome landscape of pancreatic neuroendocrine tumours. Nature. 2017; 543(7643):65-71. DOI: 10.1038/nature21063. View

10.

Frampton G, Fichtenholtz A, Otto G, Wang K, Downing S, He J . Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing. Nat Biotechnol. 2013; 31(11):1023-31. PMC: 5710001. DOI: 10.1038/nbt.2696. View

11.

Missiaglia E, Dalai I, Barbi S, Beghelli S, Falconi M, Della Peruta M . Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathway. J Clin Oncol. 2009; 28(2):245-55. PMC: 4288616. DOI: 10.1200/JCO.2008.21.5988. View

12.

Tsunezuka H, Abe K, Shimada J, Inoue M . Pulmonary atypical carcinoid in a patient with Cowden syndrome. Interact Cardiovasc Thorac Surg. 2016; 22(6):860-2. PMC: 4986790. DOI: 10.1093/icvts/ivw046. View

13.

Nelen M, Kremer H, Konings I, Schoute F, van Essen A, Koch R . Novel PTEN mutations in patients with Cowden disease: absence of clear genotype-phenotype correlations. Eur J Hum Genet. 1999; 7(3):267-73. DOI: 10.1038/sj.ejhg.5200289. View

14.

Jiao Y, Shi C, Edil B, de Wilde R, Klimstra D, Maitra A . DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science. 2011; 331(6021):1199-203. PMC: 3144496. DOI: 10.1126/science.1200609. View

15.

Lee H, Ha S, Roh M . Altered Expression of PTEN and Its Major Regulator MicroRNA-21 in Pulmonary Neuroendocrine Tumors. Korean J Pathol. 2014; 48(1):17-23. PMC: 3950230. DOI: 10.4132/KoreanJPathol.2014.48.1.17. View

16.

Berger A, Pandolfi P . Haplo-insufficiency: a driving force in cancer. J Pathol. 2010; 223(2):137-46. DOI: 10.1002/path.2800. View

17.

Pilarski R, Eng C . Will the real Cowden syndrome please stand up (again)? Expanding mutational and clinical spectra of the PTEN hamartoma tumour syndrome. J Med Genet. 2004; 41(5):323-6. PMC: 1735782. DOI: 10.1136/jmg.2004.018036. View

18.

Marth T, Schmitt-Graff A, Zimmer T, Riecken E, Wiedenmann B . [Gastric hamartoma and thyroid gland carcinoma with follicular and neuroendocrine differentiation in Cowden syndrome]. Z Gastroenterol. 1996; 34(1):30-5. View

19.

Dasari A, Shen C, Halperin D, Zhao B, Zhou S, Xu Y . Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States. JAMA Oncol. 2017; 3(10):1335-1342. PMC: 5824320. DOI: 10.1001/jamaoncol.2017.0589. View

20.

Gagliano T, Bellio M, Gentilin E, Mole D, Tagliati F, Schiavon M . mTOR, p70S6K, AKT, and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids. Endocr Relat Cancer. 2013; 20(4):463-75. DOI: 10.1530/ERC-13-0042. View